News | November 13, 2025
Biotronik selects Syensqo’s Eviva Polysulfone for pacemaker header components
The high-performance polymer’s transparency and biocompatibility support precise implantation and long-term reliability
The high-performance polymer’s transparency and biocompatibility support precise implantation and long-term reliability
Enzomenib, an oral, small-molecule inhibitor designed to disrupt the menin-MLL protein interaction involved in leukemogenesis
With over two decades of extensive experience, Lal has established himself as a transformational leader in the FMCG and consumer goods sectors
Cobenfy generated $43 million in third-quarter sales, up from $35 million in the second quarter
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Maria Soler Nunez appointed as Chief Quality Officer
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
Sarepta has also entered into an agreement with Arrowhead to transfer 2,660,989 shares of Arrowhead common stock in satisfaction of $50 million of the company’s previously announced $100 million milestone payment obligation
Baruah will lead strategy, growth, and transformation across the HLS vertical, focusing on expanding digital health capabilities and accelerating AI adoption
The SURPASS-CVOT study met its primary objective by demonstrating that Mounjaro (tirzepatide) was non-inferior to Trulicity
Subscribe To Our Newsletter & Stay Updated
